Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (82)

2024

  1. Considerations involved in elective generator replacement of implantable cardioverter-defibrillators: balancing risks, benefits, and individual factors

    Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 2-5

  2. Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2647-2664), 10.1007/s12094-023-03215-4)

    Clinical and Translational Oncology

  3. Use of Tirzepatide in Adults with Type 2 Diabetes Mellitus: Scientific Evidence and Practical Aspects

    Diabetes Therapy, Vol. 15, Núm. 7, pp. 1501-1512

  4. XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (I)

    Revista de neurologia, Vol. 79, Núm. 1, pp. 21-29

  5. XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (II)

    Revista de neurologia, Vol. 79, Núm. 2, pp. 51-66

2023

  1. Impact of fragility fractures in postmenopausal Spanish women with osteoporosis

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 15, Núm. 4, pp. 135-143

  2. Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial

    Journal of Bone and Mineral Research, Vol. 38, Núm. 4, pp. 471-479

  3. Medical help-seeking intentions among patients with early Alzheimer’s disease

    Frontiers in Psychiatry, Vol. 14

  4. SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)

    Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2647-2664

  5. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)

    Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30

  6. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)

    Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60

2022

  1. Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain

    Neurology and Therapy, Vol. 11, Núm. 3, pp. 1183-1192

  2. Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

    Neurologia, Vol. 37, Núm. 8, pp. 615-630

  3. High prevalence of intrathecal IgA synthesis in multiple sclerosis patients

    Scientific Reports, Vol. 12, Núm. 1

  4. Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease

    Journal of Alzheimer's disease : JAD, Vol. 90, Núm. 2, pp. 719-726

  5. Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER)

    European Journal of Cancer, Vol. 161, pp. 26-37

  6. Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women

    Journal of Bone and Mineral Research

2021

  1. Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years

    Multiple Sclerosis and Related Disorders, Vol. 49

  2. Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial

    Journal of Bone and Mineral Research, Vol. 36, Núm. 10, pp. 1967-1978

  3. The role of bronchoscopy in patients with sars-cov-2 pneumonia

    ERJ Open Research, Vol. 7, Núm. 3